BMEA 10-Q: SEC filing
Biomea Fusion
Filed with the SEC on · accession 0001193125-26-455592
BMEA filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -8.1% by the first close after the filing.
Summary of the filing
Biomea Fusion filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results including a net loss and cash position, along with details of prior equity financings and ongoing clinical development activities.
Key details
How BMEA stock reacted
Close before
$0.59
Nov 9, 2026
First close after
-8.07%
$0.55
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for BMEA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BMEA?
Click hereFrequently asked questions
What did BMEA file with the SEC on Nov 10, 2026?
BMEA filed a 10-Q (SEC filing). Biomea Fusion filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results including a net loss and cash position, along with details of prior equity financings and ongoing clinical development activities.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did BMEA stock react to this filing?
BMEA closed at $0.59 before the filing and $0.55 on Nov 10, 2026 (-8.07%).
Other BMEA SEC filings
- 8-K · SEC filingOct 14, 2026
- 424B5 · Secondary offeringSep 22, 2026
- 8-K · SEC filingSep 22, 2026
- 8-K · SEC filingAug 5, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · Board changeJun 11, 2026
- 8-K · SEC filingMay 11, 2026
- 10-Q · SEC filingMay 11, 2026
- 8-K · Fda approvalApr 28, 2026
- DEF 14A · Board changeApr 27, 2026
Get alerts when BMEA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days